AIC
FBRX

AWM Investment Company’s Forte Biosciences FBRX Stock Holding History

AWM Investment Company’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.73M Buy
222,500
+22,500
+11% +$534K 0.41% 61
2026
Q1 		$5.18M Sell
200,000
-36,821
-16% -$1.06M 0.57% 45
2025
Q4 		$6.46M Sell
236,821
-25,000
-10% -$438K 0.62% 48
2025
Q3 		$3.93M Buy
+261,821
New +$3.02M 0.37% 67

Other funds holding FBRX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

AWM Investment Company's FBRX Position: Q2 2026 in Review

AWM Investment Company increased its Forte Biosciences (FBRX) stake by 11% in Q2 2026, buying an estimated $534K and bringing the position to 222,500 shares worth $4.73M. The position accounts for 0.41% of the portfolio, ranked #61.

AWM Investment Company first reported a position in FBRX in Q3 2025 and has held it in 4 quarters since. The position peaked at $6.46M in Q4 2025. 86 funds tracked by Wall St. Rank hold FBRX as of Q2 2026.

  • AWM Investment Company held 222,500 shares of Forte Biosciences worth $4.73M as of Q2 2026.
  • AWM Investment Company bought 22,500 Forte Biosciences shares in Q2 2026, an estimated $534K.
  • Forte Biosciences made up 0.41% of AWM Investment Company's portfolio in Q2 2026, its #61 holding.
  • AWM Investment Company first reported a position in Forte Biosciences in Q3 2025 and has held it in 4 quarters since.
  • AWM Investment Company's Forte Biosciences position peaked at $6.46M in Q4 2025.
  • 86 funds tracked by Wall St. Rank held Forte Biosciences as of Q2 2026.

Based on AWM Investment Company's 13F filing for Q2 2026, filed 14 Aug 2026.